Study of the stability of packaging and storage conditions of human mesenchymal stem cell for intra-arterial clinical application in patient with critical limb ischemia

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 86, Issue 3, 2014, Pages 459-468

  Gálvez Martín, Patricia ^a,d   Hmadcha, Abdelkrim ^a,b   Soria, Bernat ^a,b   Calpena Campmany, Ana C ^c   Clares Naveros, Beatriz ^d  

^a CABIMER Andalusian Center for Molecular Biology and Regenerative Medicine CSIC University of Seville UPO   (Spain)

^b INSTITUTO DE SALUD CARLOS III   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

^d UNIVERSITY OF GRANADA   (Spain)

Author keywords

Adipose mesenchymal stem cell; Critical limb ischemia; Injectable; Intra arterial; Packaging; Storage

Indexed keywords

ALBUMIN; CALCIUM CHLORIDE PLUS POTASSIUM CHLORIDE PLUS SODIUM CHLORIDE; GLUCOSE;

ADIPOCYTE; ADIPOGENESIS; ARTICLE; BIOCOMPATIBILITY; BONE DEVELOPMENT; CELL AGGREGATION; CELL COUNT; CELL COUNTING; CELL CULTURE; CELL STRUCTURE; CELL SURVIVAL; CELL SUSPENSION; CELL VIABILITY; CHROMOSOME ABERRATION; CONTROLLED STUDY; CRITICAL LIMB ISCHEMIA; GENOMIC INSTABILITY; GENOTYPE; HUMAN; HUMAN CELL; IMMUNOPHENOTYPING; KARYOTYPING; MESENCHYMAL STEM CELL; OSTEOCYTE; PACKAGING; PH MEASUREMENT; PHENOTYPE; PHYSICAL CHEMISTRY; STORAGE; STORAGE TEMPERATURE; BLOOD; CHEMISTRY; CLINICAL TRIAL; DIABETIC ANGIOPATHIES; DRUG PACKAGING; DRUG STABILITY; DRUG STORAGE; HEALTH CARE FACILITY; INTRAARTERIAL DRUG ADMINISTRATION; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMA CELL; PHASE 1 CLINICAL TRIAL; PHASE 2 CLINICAL TRIAL; PHYSIOLOGY; PROCEDURES; STANDARDS;

CELLS, CULTURED; DIABETIC ANGIOPATHIES; DRUG PACKAGING; DRUG STABILITY; DRUG STORAGE; HUMANS; INJECTIONS, INTRA-ARTERIAL; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; TISSUE BANKS;

EID: 84898440585     PISSN: 09396411     EISSN: 18733441     Source Type: Journal    
DOI: 10.1016/j.ejpb.2013.11.002     Document Type: Article

References (44)

1. A. Keating Mesenchymal stromal cells: new directions Cell Stem Cell 10 2012 709 716
2. S.J. Greco, and P. Rameshwar Mesenchymal stem cells in drug/gene delivery: implications for cell therapy Ther. Deliv. 3 2012 997 1004
3. S. Thirumala, W.S. Goebel, and E.J. Woods Manufacturing and banking of mesenchymal stem cells Expert. Opin. Biol. Ther. 13 2013 673 691
4. F.E. Figueroa, F. Carrion, S. Villanueva, and M. Khoury Mesenchymal stem cell treatment for autoimmune diseases: a critical review Biol. Res. 45 2012 269 277
5. M.W. Maijenburg, C.E. van der Schoot, and C. Voermans Mesenchymal stromal cell migration: possibilities to improve cellular therapy Stem Cells Dev. 21 2012 19 29
6. R.Y. Calne, S.U. Gan, and K.O. Lee Stem cell and gene therapies for diabetes mellitus Nat. Rev. Endocrinol. 6 2010 173 177
7. R. Ruiz-Salmeron, A. de la Cuesta-Diaz, M. Constantino-Bermejo, I. Pérez-Camacho, F. Marcos-Sánchez, A. Hmadcha, and B. Soria Angiographic demonstration of neoangiogenesis after intra-arterial infusion of autologous bone marrow mononuclear cells in diabetic patients with critical limb ischemia Cell Transplant. 20 2011 1629 1639
8. P.K. Gupta, A. Chullikana, R. Parakh, S. Desai, A. Das, S. Gottipamula, S. Krishnamurthy, N. Anthony, A. Pherwani, and A.S. Majumdar A double blind randomized placebo controlled phase I/II study assessing the safety and efficacy of allogeneic bone marrow derived mesenchymal stem cell in critical limb ischemia J. Transl. Med. 11 2013 143
9. M.K. Mamidi, R. Pal, S. Dey, B.J. Bin Abdullah, Z. Zakaria, M.S. Rao, and A.K. Das Cell therapy in critical limb ischemia: current developments and future progress Cytotherapy 14 2012 902 916
10. A. Liew, and T. O'Brien Therapeutic potential for mesenchymal stem cell transplantation in critical limb ischemia Stem Cell Res. Ther. 3 2012 28
11. A.K. Das, B.J. Bin Abdullah, S.S. Dhillon, A. Vijanari, C.H. Anoop, and P.K. Gupta Intra-arterial allogeneic mesenchymal stem cells for critical limb ischemia are safe and efficacious: report of a phase I study World J. Surg. 37 2013 915 922
12. M.P. de Miguel, S. Fuentes-Julian, A. Blazquez-Martinez, C.Y. Pascual, M.A. Aller, J. Arias, and F. Arnalich-Montiel Immunosuppressive properties of mesenchymal stem cells: advances and applications Curr. Mol. Med. 12 2012 574 591
13. M. Dominici, K. Le Blanc, I. Mueller, I. Slaper-Cortenbach, F. Marini, D. Krause, R. Deans, A. Keating, D. Prockop, and E. Horwitz Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement Cytotherapy 8 2006 315 317
14. R.G. Gomez-Mauricio, A. Acarregui, F.M. Sánchez-Margallo, V. Crisóstomo, I. Gallo, R.M. Hernández, J.L. Pedraz, G. Orive, and M.F. Martín-Cancho A preliminary approach to the repair of myocardial infarction using adipose tissue-derived stem cells encapsulated in magnetic resonance-labelled alginate microspheres in a porcine model Eur. J. Pharm. Biopharm. 84 2013 29 39
15. P.G. Martin, A.R. Martinez, V.G. Lara, B.C. Naveros, Regulatory considerations in production of a cell therapy medicinal product in Europe to clinical research, Clin. Exp. Med. 27 (in press), doi: 10.1007/s10238-012-0213- 6.
16. M.B. Koh, and G. Suck Cell therapy: promise fulfilled? Biologicals 40 2012 214 217
17. P. Galvez, B. Clares, A. Hmadcha, A. Ruiz, and B. Soria Development of a cell-based medicinal product: regulatory structures in the European Union Br. Med. Bull. 105 2012 85 105
18. H. Uludag, P. De Vos, and P.A. Tresco Technology of mammalian cell encapsulation Adv. Drug Deliv. Rev. 42 2000 29 64
19. R. Pal, M. Hanwate, and S.M. Totey Effect of holding time, temperature and different parenteral solutions on viability and functionality of adult bone marrow-derived mesenchymal stem cells before transplantation J. Tissue Eng. Regen. Med. 2 2008 436 444
20. European Medicines Agency (EMA), ICH Topic Q 1 E, Evaluation of Stability Data, Step 5, Note for Guidance on Evaluation of Stability Data (CPMP/ICH/420/02), 2003. < http://www.ema.europa.eu/docs/en-GB/document- library/Scientific-guideline/2009/09/WC500002649.pdf > (accessed 20.06.13.
21. B.C. Heng, C.M. Cowan, and S. Basu Temperature and calcium ions affect aggregation of mesenchymal stem cells in phosphate buffered saline Cytotechnology 58 2008 69 75
22. M.F. Pittenger, A.M. Mackay, S.C. Beck, R.K. Jaiswal, R. Douglas, J.D. Mosca, M.A. Moorman, D.W. Simonetti, S. Craig, and D.R. Marshak Multilineage potential of adult human mesenchymal stem cells Science 284 1999 143 147
23. N.P. Bochkov, V.A. Nikitina, O.A. Buyanovskaya, E.S. Voronina, D.V. Goldstein, N.P. Kuleshov, A.A. Rzhaninova, and I.N. Chaushev Aneuploidy of stem cells isolated from human adipose tissue Bull. Exp. Biol. Med. 146 2008 344 347
24. Y. Wang, Z.B. Han, Y.P. Song, and Z.C. Han Safety of mesenchymal stem cells for clinical application Stem Cells Int. 2012 2012 1 4
25. S. Boozer, N. Lehman, U. Lakshmipathy, B. Love, A. Raber, A. Maitra, R. Deans, M.S. Rao, and A.E. Ting Global characterization and genomic stability of human multistem, a multipotent adult progenitor cell J. Stem Cells 4 2009 17 28
26. N.P. Bochkov, E.S. Voronina, N.V. Kosyakova, T. Liehr, A.A. Rzhaninova, L.D. Katosova, V.I. Platonova, and D.V. Gol'dshtein Chromosome variability of human multipotent mesenchymal stromal cells Bull. Exp. Biol. Med. 143 2007 122 126
27. G.V. Rosland, A. Svendsen, A. Torsvik, E. Sobala, E. McCormack, H. Immervoll, J. Mysliwietz, J.C. Tonn, R. Goldbrunner, P.E. Lønning, R. Bjerkvig, and C. Schichor Long-term cultures of bone marrow-derived human mesenchymal stem cells frequently undergo spontaneous malignant transformation Cancer Res. 69 2009 5331 5339
28. M.E. Bernardo, N. Zaffaroni, F. Novara, A.M. Cometa, M.A. Avanzini, A. Moretta, D. Montagna, R. Maccario, R. Villa, M.G. Daidone, O. Zuffardi, and F. Locatelli Human bone marrow derived mesenchymal stem cells do not undergo transformation after long-term in vitro culture and do not exhibit telomere maintenance mechanisms Cancer Res. 67 2007 9142 9149
29. J.C. Ra, I.S. Shin, S.H. Kim, S.K. Kang, B.C. Kang, H.Y. Lee, Y.J. Kim, J.Y. Jo, E.J. Yoon, H.J. Choi, and E. Kwon Safety of intravenous infusion of human adipose tissue-derived mesenchymal stem cells in animals and humans Stem Cells Dev. 20 2011 1297 1308
30. H.S. Sohn, J.S. Heo, H.S. Kim, Y. Choi, and H.O. Kim Duration of in vitro storage affects the key stem cell features of human bone marrow-derived mesenchymal stromal cells for clinical transplantation Cytotherapy 15 2013 460 466
31. European Medicines Agency (EMA), Guideline on Human Cell-based Medicinal Products, Doc. Ref.EMEA/CHMP/410869/412006, 2008. < http://www.ema.europa.eu/ docs/en-GB/document-library/Scientific-guideline/2009/09/WC500003894.pdf > (accessed 25.06.13).
32. K.S. Louis, and A.C. Siegel Cell viability analysis using trypan blue: manual and automated methods Methods Mol. Biol. 740 2011 7 12
33. J. Bayani, and J.A. Squire Traditional banding of chromosomes for cytogenetic analysis Curr. Protoc. Cell. Biol. 22 2004 22 23
34. J.R. Gonzalez-Garcia, and J.P. Meza-Espinoza Use of the International System for Human Cytogenetic Nomenclature (ISCN) Blood 108 2006 3952 3953
35. The European Pharmacopoeia, sixth ed., EDQM, Strasbourg, France, 2008.
36. 2 aqueous suspensions in the presence of sodium polyacrylate Colloid Surf. A - Physicochem. Eng. Asp. 436 2013 1111 1120
37. A.F. Sierra, M.L. Ramírez, A.C. Campmany, A.R. Martínez, and B.C. Naveros In vivo and in vitro evaluation of the use of a newly developed melatonin loaded emulsion combined with UV filters as a protective agent against skin irradiation J. Dermatol. Sci. 69 2013 202 214
38. R. Skalak, N. Ozkaya, and T.C. Skalak Biofluid mechanics Annu. Rev. Fluid Mech. 21 1989 167 204
39. M.M. Cross Rheology of non-Newtonian fluids - a new flow equation for pseudoplastic systems J. Colloid Sci. 20 1965 417 437
40. S. Sen, E.N. Chini, and M.J. Brown Complications after unintentional intra-arterial injection of drugs: risks, outcomes, and management strategies Mayo Clin. Proc. 80 2005 783 795
41. F. Fernández-Campos, A.C. Calpena-Campmany, G. Rodríguez-Delgado, O. López-Serrano, and B. Clares-Naveros Development and characterization of a novel nystatin-loaded nanoemulsion for the buccal treatment of candidosis: Ultrastructural effects and release studies J. Pharm. Sci. 101 2012 3739 3752
42. I.A. Potapova, P.R. Brink, I.S. Cohen, and S.V. Doronin Culturing of human mesenchimal stem cells as 3-D aggregates induces functional expression of CXCR4 that regulates adhesion to endothelial cells J. Biol. Chem. 283 2008 13100 13107
43. V. Antonenas, F. Garvin, M. Webb, M. Sartor, K.F. Bradstock, and D. Gottlieb Fresh PBSC harvests, but not BM, show temperature-related loss of CD34 viability during storage and transport Cytotherapy 8 2006 158 165
44. K. Muraki, M. Hirose, N. Kotobuki, Y. Kato, H. Machida, Y. Takakura, and H. Ohgushi Assessment of viability and osteogenic ability of human mesenchymal stem cells after being stored in suspension for clinical transplantation Tissue Eng. 12 2006 1711 1719